OysterMax
Commercial- Indications
- Zinc deficiency, Energy support
Company intelligence / Profile preview
Marine Health Foods produces commercial dietary supplements derived from marine sources, notably wild oysters. Their flagship product, OysterMax®, contains a broad spectrum of trace elements, vitamins, amino acids, and omega fatty acids. The company emphasizes natural bioavailability and nutrient synergy in its products. No clinical trial data or pharmaceutical development pipeline has been reported; the company operates at the commercial supplement stage with regulatory registrations in the EU and US for food safety compliance.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marine Health Foods.